RecruitingEarly Phase 1NCT00200889

Mapping Auricular Vagus Nerve Circuitry

Auricular Vagal Nerve Stimulation for Gastric and Brain Outcomes

Sponsor

Massachusetts General Hospital

Enrollment

50 participants

Start Date

Aug 22, 2023

Study Type

INTERVENTIONAL

Conditions

Healthy

Summary

This study will determine how noninvasive nerve stimulation affects human brain, stomach, and autonomic activity.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

Adults 18-65
Functional dyspepsia

Exclusion Criteria1

Any condition contraindicating an fMRI brain scan

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEactive TEAS

non-painful active transcutaneous electro-acupoint stimulation will be delivered to the abdomen and leg

Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00200889

Related Trials

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

NCT071696301 location